InsidersTradesSigma
Discover the detailed record of transactions filed by McKelligon Brian, Director General. Officer active across 1 company, notably Akoya Biosciences, Inc.. In total, 2 filings have been published. Activity tracked since 15 June 2022. The latest transaction was filed on 15 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 de 2 declaraciones
Brian McKelligon is President and CEO of Akoya Biosciences, Inc. He leads the company and is responsible for its overall strategy and operations. His leadership is crucial for the company's innovation and growth.